To include your compound in the COVID-19 Resource Center, submit it here.

Therapeutics: HIF1A antisense RNA 2 (HIF1A-AS2)

Cancer

INDICATION: Brain cancer

Patient sample and mouse studies suggest inhibiting HIF1A-AS2 could

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE